Lab-Grown immune cells deployed to fight viruses in vulnerable transplant patients
NCT ID NCT03180216
Summary
This early-stage study is testing the safety of a special immune cell therapy for people who have had a stem cell transplant. The therapy uses T-cells from the transplant donor that are grown in a lab to fight seven different viruses that can cause dangerous infections after transplant. The study will give these cells to 32 patients either to prevent infections or to treat active infections that haven't responded to standard drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIRAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens National Medical Center
Washington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.